Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.47 -0.03 (-6.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Reviva Pharmaceuticals Holdings (RVPH) Total Non-Current Liabilities (2021 - 2025)

Updated

Reviva Pharmaceuticals Holdings (RVPH) recorded Total Non-Current Liabilities of $7.28 million in Q4 2025, down 50.2% from $14.6 million a year earlier and down 25.3% from the prior quarter.

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Total Non-Current Liabilities (2021 - 2025) Analysis & Trends

Starting with Q1 2021, Reviva Pharmaceuticals Holdings' Total Non-Current Liabilities history includes 20 quarters.

  • Annual Total Non-Current Liabilities has a five-year compound annual growth rate of 40.4% (FY2020 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $14.6 million in FY2024 (-15.0%), $17.18 million in FY2023 (+72.4%) and $9.96 million in FY2022.
  • The Q4 2025 figure is the lowest quarterly Total Non-Current Liabilities since Q3 2022.
  • On a year-over-year basis, Total Non-Current Liabilities has declined for five consecutive quarters, with an average decline of 12.1% over the last eight quarters.
  • Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 555.2% in Q3 2022, against a decline of 50.2% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $9.74 million (Q3 2025), $12.08 million (Q2 2025) and $11.51 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Reviva Pharmaceuticals Holdings 6.16 Mn 6.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 7.28 Mn
Sep 30, 2025 9.74 Mn
Jun 30, 2025 12.08 Mn
Mar 31, 2025 11.51 Mn
Dec 31, 2024 14.60 Mn
Sep 30, 2024 17.53 Mn
Jun 30, 2024 13.94 Mn
Mar 31, 2024 14.49 Mn
Dec 31, 2023 17.18 Mn
Sep 30, 2023 17.32 Mn
Jun 30, 2023 12.64 Mn
Mar 31, 2023 10.73 Mn
Dec 31, 2022 9.96 Mn
Sep 30, 2022 6.38 Mn
Jun 30, 2022 4.48 Mn
Mar 31, 2022 3.62 Mn
Dec 31, 2021 2.34 Mn
Sep 30, 2021 973,700.00
Jun 30, 2021 1.16 Mn
Mar 31, 2021 1.10 Mn
API Access

Reviva Pharmaceuticals Holdings Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RVPH&period=max&api_key=YOUR_API_KEY